{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-019997","form_type":"8-K","ticker":"CLCS","cik":"0001569340","company_name":"Cell Source, Inc.","filed_at":"2022-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.206997+00:00","generated_at":"2026-06-24T09:58:49.611642+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Two directors resign from Cell Source board, no disagreements cited","bullets":["Ben Friedman resigned as director on July 18, 2022.","David Zolty resigned as director on the same date.","Neither resignation was due to any disagreement with the company.","No replacements have been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-019997","json":"https://secwatch.observer/filing/0001493152-22-019997.json","markdown":"https://secwatch.observer/filing/0001493152-22-019997.md","text":"https://secwatch.observer/filing/0001493152-22-019997.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/0001493152-22-019997-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:58:49.611642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6dc563e851","claim":"David Zolty resigned as director at Cell Source, Inc..","evidence_excerpt":"On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/0001493152-22-019997-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"f5f70363d8","claim":"Ben Friedman resigned as director at Cell Source, Inc..","evidence_excerpt":"On July 18, 2022, each of Ben Friedman and David Zolty resigned his position as a director of Cell Source, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1569340/000149315222019997/0001493152-22-019997-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}